Home > Insider Trading > Filing (0001415889-23-005120)

Filing Details

Accession Number:: 0001415889-23-005120
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-03-17 16:30:16
Reporting Period:: 2023-03-16

Accepted Time:: 2023-03-17 16:30:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1082554	United Therapeutics Corp	UTHR	Pharmaceutical Preparations (2834)	521984749

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1231589	A Paul Mahon	C/O United Therapeutics Corporation 1040 Spring Street Silver Spring MD 20910	Evp & General Counsel	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2023-03-16	6,000	$120.26	42,599	No	4	M	Direct
Common Stock	Disposition	2023-03-16	475	$211.87	42,124	No	4	S	Direct
Common Stock	Disposition	2023-03-16	1,277	$213.61	40,847	No	4	S	Direct
Common Stock	Disposition	2023-03-16	2,522	$214.52	38,325	No	4	S	Direct
Common Stock	Disposition	2023-03-16	1,526	$215.40	36,799	No	4	S	Direct
Common Stock	Disposition	2023-03-16	200	$216.09	36,599	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options	Disposition	2023-03-16	6,000	$0.00	6,000	$120.26

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
44,500	2017-03-15	2026-03-15	No	4	M	Direct

Footnotes

This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
Includes 112 shares acquired on March 3, 2023, under the United Therapeutics Corporation Employee Stock Purchase Plan.
This transaction was executed in multiple trades at prices ranging from $211.80 to $212.255. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $212.98 to $213.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $214.00 to $214.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $215.02 to $215.695. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $216.06 to $216.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.